Meloxicam 7.5 mg is a prescription nonsteroidal anti-inflammatory drug (NSAID) used primarily to treat osteoarthritis and rheumatoid arthritis. It belongs to a class of NSAIDs that preferentially targets the COX-2 enzyme, giving it a somewhat gentler profile on the stomach compared to older anti-inflammatory drugs. The 7.5 mg dose is the standard starting point for most adults, taken once daily, and for many people it provides enough relief without needing to go higher.
How Meloxicam Works
Your body produces enzymes called cyclooxygenase (COX) that help make prostaglandins, chemical messengers involved in inflammation, pain, and fever. There are two main forms of this enzyme. COX-1 runs constantly and does housekeeping work like protecting the stomach lining and supporting kidney blood flow. COX-2 ramps up when tissue is injured or inflamed. Traditional NSAIDs like ibuprofen and naproxen block both forms, which is why they can cause stomach irritation even while effectively reducing pain.
Meloxicam is considered a preferential COX-2 inhibitor, meaning it blocks the inflammation-driving enzyme more than the protective one.1PubMed. Meloxicam: a selective COX-2 inhibitor non-steroidal anti-inflammatory drug This selectivity is not absolute the way it is with drugs like celecoxib, which were engineered specifically for COX-2. Meloxicam sits somewhere in between: more selective than ibuprofen or naproxen, less selective than celecoxib. Researchers have described it as combining anti-inflammatory effectiveness with improved tolerability.2PubMed. Meloxicam: selective COX-2 inhibition in clinical practice In practical terms, this means the stomach-related side effects tend to be milder or less frequent than with older NSAIDs, though they are not eliminated.
What Meloxicam 7.5 mg Is Prescribed For
The two main conditions meloxicam is approved for in the United States are osteoarthritis and rheumatoid arthritis. Juvenile rheumatoid arthritis is also an approved use in children age two and older, typically using a liquid suspension form dosed by weight.
For osteoarthritis, a 12-week trial comparing meloxicam at different doses to both placebo and diclofenac found that the 7.5 mg dose was significantly more effective than placebo across all measured outcomes, with improvement showing up within two weeks and holding steady through the end of the trial.3JAMA Internal Medicine. Safety and Efficacy of Meloxicam in the Treatment of Osteoarthritis: A 12-Week, Double-blind, Multiple-Dose, Placebo-Controlled Trial Pain relief improved further at 15 mg, so doctors sometimes step the dose up if 7.5 mg is not enough on its own.
For rheumatoid arthritis, a six-month head-to-head trial showed meloxicam 7.5 mg performed comparably to naproxen 750 mg on most measures, including patient-reported pain and the number of painful or swollen joints.4PubMed. A six-month double-blind trial to compare the efficacy and safety of meloxicam 7.5 mg daily and naproxen 750 mg daily in patients with rheumatoid arthritis A separate three-week study of over 400 rheumatoid arthritis patients found that both 7.5 mg and 15 mg were well tolerated and effective, with significant improvements in joint tenderness and morning pain.5PubMed. A double-blind, three-week study to compare the efficacy and safety of meloxicam 7.5 mg and meloxicam 15 mg in patients with rheumatoid arthritis
Doctors also prescribe meloxicam off-label for other painful or inflammatory conditions, including ankylosing spondylitis, tendinitis, bursitis, gout flares, and post-surgical pain management. The off-label uses are common enough that you may receive meloxicam for something not listed on the official label, which is standard practice across medicine when your doctor judges the benefit outweighs the risk.
Dosage and How to Take It
The typical starting dose for adults is 7.5 mg once a day, taken by mouth. If that is not providing enough relief, a doctor may increase it to 15 mg once a day, which is the maximum recommended dose. Going above 15 mg does not add further benefit and increases the likelihood of side effects. Meloxicam can be taken with or without food, though taking it with a meal or a glass of water can reduce the chance of stomach discomfort.
The drug is available as a tablet, a capsule, and an oral suspension (liquid). A bioequivalence study found that the liquid form is absorbed at the same total amount as capsules, though it gets into the bloodstream a bit faster after a single dose.6PubMed. Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations The liquid version is particularly useful for people who have difficulty swallowing pills, including children and some older adults. Regardless of the form, the general principle with any NSAID applies here: use the lowest effective dose for the shortest time needed.
Meloxicam has a long half-life of about 15 to 20 hours in most adults, which is why once-daily dosing works. It can take several days of consistent use to reach steady levels in the blood, so you should not expect full effect from the first pill. If you miss a dose, take it when you remember unless it is nearly time for the next one. Do not double up.
Common Side Effects
The most frequently reported side effects involve the digestive system. A large general-practice study following over 19,000 patients found a rate of about 28 cases of dyspepsia (stomach pain, bloating, or indigestion) per 1,000 patient-months of use during the first month.7PubMed Central. The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19 087 patients in general practice in England: cohort study That works out to roughly 1 in 35 users experiencing stomach trouble in the early weeks. Other common side effects include nausea, diarrhea, headache, dizziness, and mild fluid retention (swelling in the ankles or feet).
Compared to some older NSAIDs, meloxicam’s GI side effect profile is relatively favorable. In a study comparing meloxicam at 7.5 mg and 15 mg against celecoxib after knee replacement surgery, the rates of gastrointestinal bleeding were not significantly different between any of the groups.8PubMed Central. Meloxicam versus Celecoxib for Postoperative Analgesia after Total Knee Arthroplasty: Safety, Efficacy and Cost That said, no NSAID is completely free of stomach risk, especially with prolonged use or in people who have a history of ulcers.
Cardiovascular Risks
All NSAIDs carry a boxed warning about increased risk of heart attack and stroke. This is a class-wide concern, not unique to meloxicam, though the degree of risk varies among individual drugs. A population-based study estimated that current meloxicam use was associated with roughly a 38% increased risk of heart attack compared to people not currently using any NSAID.9PubMed Central. Meloxicam and Risk of Myocardial Infarction: A Population-based Nested Case-control Study For context, diclofenac showed a similar increase (about 37%), while naproxen showed a smaller, non-statistically-significant increase of 12% in the same study.
A separate nationwide analysis comparing cardiovascular outcomes across several NSAIDs found that diclofenac was associated with higher cardiovascular event rates than meloxicam.10PubMed. Cardiovascular Risks of Diclofenac Versus Other Older COX-2 Inhibitors (Meloxicam and Etodolac) and Newer COX-2 Inhibitors (Celecoxib and Etoricoxib): A Series of Nationwide Emulated Trials The picture that emerges is that meloxicam sits in the middle of the pack for cardiovascular risk among NSAIDs: not the safest option (that distinction tends to go to naproxen), not the riskiest (diclofenac and some selective COX-2 inhibitors carry higher signals), but not risk-free either.
If you have existing heart disease, a history of heart attack or stroke, or significant cardiovascular risk factors like uncontrolled high blood pressure, your doctor will weigh whether an NSAID is appropriate at all. The risk increases with higher doses and longer duration of use, which is another reason the 7.5 mg starting dose matters. For many patients with mild to moderate arthritis pain, staying at the lower dose reduces cardiovascular exposure while still controlling symptoms.
Kidney and Liver Concerns
Because prostaglandins help regulate blood flow to the kidneys, any NSAID that suppresses their production can affect kidney function. In people with healthy kidneys who are well hydrated, this is usually not a problem at standard doses. The concern is greatest for people who already have reduced kidney function, are dehydrated, take diuretics or blood pressure medications, or are elderly. In those groups, NSAIDs including meloxicam can trigger acute kidney injury by constricting the blood vessels that supply the kidneys.11European Journal of Internal Medicine. Acute kidney injury associated with non-steroidal anti-inflammatory drugs
In rare cases, more severe kidney reactions have been reported. A case report described a 65-year-old woman who developed nephrotic syndrome and acute tubular necrosis after taking meloxicam 15 mg for just three days to treat tendinitis.12PubMed. Nephrotic syndrome and acute tubular necrosis due to meloxicam use Cases like that are uncommon but underscore the importance of monitoring if you take meloxicam long-term, especially if you have any kidney risk factors. A study of patients with ankylosing spondylitis on long-term NSAID therapy found a statistically significant change in creatinine levels (a kidney function marker) over three years of continuous use.13Reumatismo / PAGEPress. Assessment of liver and kidney function in patients with ankylosing spondylitis on long-term non-steroidal anti-inflammatory drug therapy
Liver injury from meloxicam is less commonly discussed but does occur. NSAIDs in general can cause mild elevations in liver enzymes, which usually resolve on their own, but occasionally more serious liver damage can develop. Doctors typically check liver and kidney function periodically if you are on meloxicam for an extended period. If you notice dark urine, unusual fatigue, or yellowing of the skin or eyes, those warrant a prompt call to your doctor.
Drug Interactions Worth Knowing About
Meloxicam interacts with several commonly used medications. Blood thinners are one of the biggest concerns. An animal study showed that meloxicam enhanced the effect of the anticoagulant phenprocoumon at high doses.14PubMed. General pharmacology of meloxicam–Part II In clinical practice, combining meloxicam with warfarin, heparin, or newer blood thinners raises the risk of bleeding, particularly in the GI tract. If you take any blood thinner, your doctor needs to know before prescribing meloxicam.
Other interactions to be aware of:
- ACE inhibitors and ARBs: These blood pressure medications rely partly on prostaglandins to work, so meloxicam can blunt their effect and raise blood pressure. The combination also increases the risk of kidney problems, especially if you add a diuretic to the mix.
- Lithium: NSAIDs reduce lithium clearance through the kidneys, which can push lithium levels into a toxic range. If you take lithium for bipolar disorder, your levels should be monitored closely when starting or stopping meloxicam.
- Methotrexate: NSAIDs can slow the elimination of methotrexate, raising the risk of its side effects. This is a concern for people using methotrexate for rheumatoid arthritis or certain cancers.
- Other NSAIDs and aspirin: Stacking meloxicam with another NSAID (including over-the-counter ibuprofen) does not double the benefit but does roughly double the side-effect risk. Low-dose aspirin for heart protection is a separate situation, and if you take daily aspirin, your doctor can advise on timing and risk.
- SSRIs: Certain antidepressants combined with any NSAID increase the risk of gastrointestinal bleeding. The risk is modest for most people but worth mentioning to your prescriber.
Genetic Variation in How Your Body Processes Meloxicam
Meloxicam is broken down in the liver primarily by an enzyme called CYP2C9. The gene encoding this enzyme comes in several variants, and certain versions process meloxicam much more slowly than others. In a pharmacokinetic study, people carrying one copy of the CYP2C9*13 variant had total drug exposure about 2.4 times higher than people with the common version of the gene. Their bodies cleared the drug at only about 38% of the normal rate, and the drug’s half-life was nearly twice as long.15PubMed Central. Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
What that means in real terms: someone with a slow-metabolizer variant effectively gets a much larger dose from the same 7.5 mg tablet. They are more likely to experience side effects and may do better on a lower dose. The CYP2C9*13 variant is most common in East Asian populations, while other slow-metabolizer variants like CYP2C9*2 and *3 are more frequent in people of European descent. Pharmacogenomic testing can identify these variants, though it is not routinely ordered before prescribing meloxicam. If you have had unusual sensitivity to NSAIDs or other medications metabolized by CYP2C9 (like warfarin), it might be worth discussing genetic testing with your doctor.
Brand Name vs Generic
Meloxicam was originally sold under the brand name Mobic, but the patent expired years ago and multiple generic versions are now available. A bioequivalence study directly comparing a generic meloxicam formulation to branded Mobic found that the two were pharmacokinetically interchangeable. The 90% confidence intervals for key measurements like total drug exposure and peak concentration all fell within the standard acceptance range, confirming that generic and branded versions deliver the same amount of drug.16Dove Press. Comparative pharmacokinetic and pharmacodynamic evaluation of branded and generic formulations of meloxicam in healthy male volunteers
From a practical standpoint, the generic versions cost a fraction of what Mobic once did. Without insurance, a month’s supply of generic meloxicam 7.5 mg typically runs a few dollars at most pharmacies, making it one of the most affordable prescription anti-inflammatory options available. There is no clinical reason to prefer the brand name over a generic, and most pharmacies will automatically dispense the generic unless a doctor specifically requests otherwise.
Why Veterinary Meloxicam Is Not the Same Thing
Meloxicam is also widely used in veterinary medicine for dogs, cats, horses, cattle, and pigs. A comprehensive review of meloxicam pharmacokinetics across species found that while the drug has good bioavailability in most animals (roughly 85 to 95%), the way different species process and eliminate it varies considerably.17Multidisciplinary Digital Publishing Institute (MDPI) / Veterinary Sciences. Pharmacokinetics of Meloxicam in Different Animal Species: A Comprehensive Review Veterinary doses range from about 0.2 to 2 mg per kilogram of body weight depending on the species, and the formulations are designed with species-specific concentrations and inactive ingredients.
This matters because pet owners occasionally wonder whether their veterinary meloxicam is the same as human meloxicam, or vice versa. The active ingredient is identical, but the concentrations, flavoring agents, and dosing are different enough that swapping between them is a bad idea. A veterinary liquid formulation might be far more concentrated per milliliter than the human oral suspension, creating a serious overdose risk if used improperly. A case report described a dog that accidentally received a massive meloxicam overdose of about 5.5 mg per kilogram and required emergency blood filtration treatment to bring drug levels down.18PubMed. Use of Activated Carbon Hemoperfusion and Hemodialysis in the Treatment of a Meloxicam Overdose in a Dog In humans, an overdose would similarly stress the kidneys and GI tract. The bottom line: do not share medications between yourself and your pet, even when the drug name is the same.
Who Should Avoid Meloxicam
Certain groups should not take meloxicam at all. People with a known allergy to aspirin or other NSAIDs that causes hives, facial swelling, or asthma-like symptoms should avoid it, because cross-reactivity within the NSAID class is common. Meloxicam is also contraindicated in the setting of coronary artery bypass graft surgery, as NSAIDs used around that procedure have been linked to increased heart events.
Pregnant women should avoid meloxicam, particularly after 30 weeks of gestation, because NSAIDs can cause premature closure of a fetal blood vessel called the ductus arteriosus and can also reduce amniotic fluid. Earlier in pregnancy, the risks are less clear-cut, but most doctors prefer to avoid NSAIDs throughout pregnancy when alternatives exist.
People with active GI bleeding, severe kidney disease, or severe liver disease are generally told to steer clear. For older adults without those absolute contraindications, meloxicam can be used cautiously, but the threshold for monitoring kidney function and watching for GI symptoms should be lower. If you are over 65, on multiple medications, or have even mildly reduced kidney function, periodic blood work is a reasonable precaution while taking any NSAID long-term.